NYSE · MIAX
Miami International Holdings, Inc.
$32.99+$1.55 (+4.93%)
Miami International Holdings, Inc. ’s quoted price sits in the lower half of its reported 52-week range, 42.26% below the high.
Loading market information…
AMEX · POAS · USD
Stock price
Quote as of Oct 30, 2026, 07:09 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Phaos Technology Holdings (Caym’s quoted price sits in the lower half of its reported 52-week range, 98.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:24 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$32.99+$1.55 (+4.93%)
Miami International Holdings, Inc. ’s quoted price sits in the lower half of its reported 52-week range, 42.26% below the high.
$23.12-$1.19 (-4.9%)
Tactile Systems Technology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.79% below the high.
$19.33-$1.11 (-5.43%)
Shoulder Innovations, Inc.’s quoted price sits in the upper half of its reported 52-week range, 21.42% below the high.
$6.86-$0.08 (-1.22%)
CapsoVision, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.4% below the high.
$1.56-$0.18 (-10.12%)
MaxCyte, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.09% below the high.
$0.74-$0.00 (-0.13%)
Hyperfine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.72% below the high.
$1.41-$0.02 (-1.05%)
CVRx, Inc.’s quoted price sits in the lower half of its reported 52-week range, 87.52% below the high.
$3.14-$0.05 (-1.57%)
Nasus Pharma Ltd.’s quoted price sits in the lower half of its reported 52-week range, 66.95% below the high.
